Search Results 81-90 of 35899 for Two-phase

  1. A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · Share · Facebook ...

  2. Small lymphocytic lymphoma - Stages - Mayo Clinic

    Stage 2 involves two or more lymph node regions on the same side of the diaphragm or one lymph node region and a site outside of the lymph nodes. Stage 3 small ...

  3. Hodgkin lymphoma (Hodgkin disease) - Stages - Mayo Clinic

    A stage 2 Hodgkin lymphoma involves two or more lymph node regions on the same side of the diaphragm. Stage 3 lymphoma. At stage 3, Hodgkin lymphoma ...

  4. Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

    Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 90% of the patients with Waldenström's macroglobulinemia.

  5. Oncology (Medical) - Clinical trials

    ... Phase 2 dose (RP2D) and schedule of KTX-1001 for ... The first part of the study includes the first two phases of therapy: Induction and Consolidation.

  6. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer - Mayo Clinic

    This study consists of two phases: Dose Escalation (Phase 1b) and Dose Expansion (Phase 2) The Dose Escalation phase will evaluate the safety and ...

  7. NAFLD and NASH research update - Mayo Clinic

    ... stage 2 to 3 liver fibrosis. ... Aqel, M.D., a specialist in gastroenterology and hepatology at Mayo Clinic's campus in Arizona is the primary investigator for ...

  8. Inotuzumab Ozogamicin And Post-Induction Chemotherapy In Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, And B-LLy - Mayo Clinic

    The first part of the study includes the first two phases of therapy: Induction and Consolidation. This part will collect information on the leukemia, as well ...

  9. Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies - Mayo Clinic

    - To assess the pharmacodynamics (PD), immune response, and preliminary disease response. Phase 2 (stage 1): to evaluate the following objectives for Isatuximab ...

  10. Phase 2 Nab®-Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects with Locally Advanced Pancreatic Cancer (LAPC) - Mayo Clinic

    This clinical study is in subjects who are 18 years old or older with locally advanced pancreatic cancer who have not received prior treatment for their ...